MedTrace Logo

Study on the Model of Smoking Cessation Intervention and Service Ability Improvement

NCT01935505 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2013-09-05

No results posted yet for this study

Summary

This is a observation non-randomized control trial, and a follow-up study on the smoking cessation.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Consulting

The physicians adopted a non-directive approach, included the five 'A' (ask, advice, assess, assist and arrange), assessing the stage of readiness in quitting smoking, strengthening clients' motivation to quit smoking using the five 'R' (relevance, risks, rewards, roadblocks and repetition) approach, and providing advice to overcome psychological craving, psychological dependence and social-cultural factors associated with tobacco dependency. Each smoker takes more than 30 min to complete the intervention.

DRUG

Nicotine patch

According to the smokers' level of nicotine dependency, disease history, cigarette consumption, prescription of drugs were provided, Nicotine Replacement Therapy, bupropion and varenicline.

BEHAVIORAL

Telephone intervention

Smokers received follow-up by a counselor at 1 week, 1, 3, 6 months and 1, 2 years using a detailed questionnaire by telephone interview. At each follow-up, we collected data, asked whether the smokers have any problem with drug use or other problems, provided problem-oriented suggestions or advice as appropriate, encouraged them to insist.

BEHAVIORAL

Consulting+Telephone+Drug intervention

Include all the above interventions

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Yao He, MD, PhD · Institute of Geriatrics, Chinese PLA General Hospital, Beijing, China

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-09-30
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01935505 on ClinicalTrials.gov